CIK 0001274737 · Non-accelerated filer<br>Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (760) 560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- Open-market buys, last 90 days
- $568,660
- in 3 filings
- Open-market sales, last 90 days
- $1,233,534
- in 4 filings
Net −$664,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-19 | Hunt Holdings Limited Partnership 10% owner | Option exercise · Warrants | −10,557 | $14.32 | $151K | 0 |
| 2019-09-19 | NMSIC Co-Investment Fund, L.P. 10% owner | Option exercise | +349,823 | $1.84 | $644K | 361,897 |
| 2019-09-19 | NMSIC Co-Investment Fund, L.P. 10% owner | Option exercise | +19,825 | $14.32 | $284K | 381,722 |
| 2019-09-19 | NMSIC Co-Investment Fund, L.P. 10% owner | Shares withheld for taxes | −49,860 | $18.58 | $926K | 331,862 |
| 2019-09-19 | NMSIC Co-Investment Fund, L.P. 10% owner | Conversion · Warrants | −280,127 | $1.84 | $515K | 0 |
| 2019-09-19 | NMSIC Co-Investment Fund, L.P. 10% owner | Conversion · Warrants | −69,696 | $1.84 | $128K | 0 |
| 2019-09-19 | NMSIC Co-Investment Fund, L.P. 10% owner | Option exercise · Warrants | −19,825 | $14.32 | $284K | 0 |
| 2019-09-19 | PALLARES EBETUEL Director | Option exercise | +3,839 | $14.32 | $55K | 4,018 |
| 2019-09-19 | PALLARES EBETUEL Director | Shares withheld for taxes | −2,960 | $18.58 | $55K | 1,058 |
| 2019-09-19 | PALLARES EBETUEL Director | Option exercise · Warrants | −3,839 | $14.32 | $55K | 0 |
| 2019-09-19 | TULLIS JAMES L L Director | Option exercise | +11,498 | $14.32 | $165K | 11,597 |
| 2019-09-19 | TULLIS JAMES L L Director | Shares withheld for taxes | −8,865 | $18.58 | $165K | 2,732 |
| 2019-09-19 | TULLIS JAMES L L Director | Option exercise · Warrants | −11,498 | $14.32 | $165K | 0 |
| 2019-09-18 | Rocca Fortunato R. President and CEO | Grant or award · Stock Option(right to buy) | +138,659 | 138,659 | ||
| 2019-09-18 | Dervieux Thierry Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +10,891 | 10,891 | ||
| 2019-09-18 | Adawi Kamal Chief Financial Officer | Grant or award · Stock Option (right to buy) | +21,635 | 21,635 | ||
| 2019-09-18 | Elliott Jeffrey Thomas Director | Grant or award · Stock Option (right to buy) | +13,613 | 13,613 | ||
| 2019-09-18 | Nova Tina Susan Director | Grant or award · Stock Option (right to buy) | +13,613 | 13,613 | ||
| 2019-09-18 | Burrell Chet Director | Grant or award · Stock Option (right to buy) | +13,613 | 13,613 |
Page 12 of 12 · 239 trades